Total Payments
$299,200
2024 Payments
$3,491
Companies
59
Transactions
1,487
Medicare Patients
14,710
Medicare Billing
$13.5M
Payment Breakdown by Category
Other$204,907 (68.5%)
Consulting$49,050 (16.4%)
Food & Beverage$25,035 (8.4%)
Travel$19,763 (6.6%)
Education$444.45 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $204,907 | 122 | 68.5% |
| Consulting Fee | $49,050 | 8 | 16.4% |
| Food and Beverage | $25,035 | 1,271 | 8.4% |
| Travel and Lodging | $19,763 | 68 | 6.6% |
| Education | $444.45 | 17 | 0.1% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$299,200
1,486 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $93,552 | 237 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $79,109 | 69 | $0 (2020) |
| United Rheumatology | $43,232 | 9 | $0 (2021) |
| ABBVIE INC. | $40,358 | 180 | $0 (2024) |
| Lilly USA, LLC | $19,554 | 86 | $0 (2024) |
| Genentech USA, Inc. | $5,498 | 58 | $0 (2023) |
| GENZYME CORPORATION | $3,842 | 21 | $0 (2024) |
| PFIZER INC. | $1,996 | 165 | $0 (2024) |
| Janssen Biotech, Inc. | $1,733 | 128 | $0 (2024) |
| UCB, Inc. | $1,482 | 86 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,491 | 139 | ANI Pharmaceuticals, Inc. ($955.60) |
| 2023 | $2,390 | 119 | Amgen Inc. ($314.22) |
| 2022 | $5,236 | 158 | Amgen Inc. ($2,923) |
| 2021 | $9,206 | 150 | United Rheumatology ($3,750) |
| 2020 | $38,466 | 88 | United Rheumatology ($17,500) |
| 2019 | $96,562 | 305 | Amgen Inc. ($60,054) |
| 2018 | $97,005 | 305 | Janssen Scientific Affairs, LLC ($51,790) |
| 2017 | $46,843 | 223 | Janssen Scientific Affairs, LLC ($19,664) |
All Payment Transactions
1,487 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/06/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | TerSera Therapeutics LLC | Quzyttir (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Acute Care | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/25/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Biosimilars | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Immunology | ||||||
| 11/14/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Immunology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,951 | 275,416 | $7.6M | $2.9M |
| 2022 | 36 | 3,642 | 272,336 | $8.7M | $3.2M |
| 2021 | 44 | 3,949 | 270,761 | $9.0M | $3.7M |
| 2020 | 40 | 4,168 | 270,112 | $8.4M | $3.7M |
Total Patients
14,710
Total Services
1,088,625
Medicare Billing
$13.5M
Procedure Codes
151
All Medicare Procedures & Services
151 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 62 | 20,751 | $1.7M | $546,157 | 31.7% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 20 | 111,625 | $998,074 | $520,026 | 52.1% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 17 | 11,050 | $906,100 | $372,466 | 41.1% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 34 | 31,734 | $1.1M | $325,338 | 29.3% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 19 | 78,000 | $933,720 | $305,573 | 32.7% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 15 | 3,600 | $486,000 | $216,251 | 44.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 84 | 8,221 | $272,853 | $151,435 | 55.5% |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | Office | 2023 | 13 | 3,230 | $323,000 | $112,439 | 34.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 158 | 1,079 | $393,835 | $105,313 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 377 | 831 | $144,588 | $78,406 | 54.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 360 | 818 | $102,206 | $53,692 | 52.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 106 | 579 | $81,060 | $31,354 | 38.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $13,920 | $7,934 | 57.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 94 | 170 | $17,000 | $7,643 | 45.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 308 | 656 | $24,928 | $6,769 | 27.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 32 | 234 | $18,720 | $5,088 | 27.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 288 | 621 | $12,420 | $4,711 | 37.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 263 | 485 | $5,820 | $4,074 | 70.0% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 35 | 35 | $2,905 | $1,702 | 58.6% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 35 | 50 | $4,000 | $1,696 | 42.4% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 289 | 620 | $11,780 | $1,643 | 13.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 38 | 38 | $5,170 | $1,456 | 28.2% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 21 | 24 | $2,280 | $995.91 | 43.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 119 | 761 | $3,805 | $603.42 | 15.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 19 | 42 | $1,806 | $507.15 | 28.1% |
About Dr. Michael Strachan, M.D
Dr. Michael Strachan, M.D is a Rheumatology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982655445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Strachan, M.D has received a total of $299,200 in payments from pharmaceutical and medical device companies, with $3,491 received in 2024. These payments were reported across 1,487 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($204,907).
As a Medicare-enrolled provider, Strachan has provided services to 14,710 Medicare beneficiaries, totaling 1,088,625 services with total Medicare billing of $13.5M. Data is available for 4 years (2020–2023), covering 151 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Richmond, VA
- Active Since 05/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1982655445
Products in Payments
- Prolia (Biological) $63,706
- STELARA (Biological) $63,619
- EVENITY (Biological) $27,702
- SIMPONI ARIA (Biological) $16,008
- OLUMIANT (Drug) $8,909
- Rinvoq (Biological) $6,032
- Actemra (Biological) $5,161
- KEVZARA (Drug) $3,623
- HUMIRA (Biological) $3,034
- RINVOQ (Drug) $1,816
- XELJANZ (Drug) $1,523
- Enbrel (Biological) $1,513
- Humira (Biological) $1,411
- Cimzia (Drug) $1,387
- PURIFIED CORTROPHIN GEL (Drug) $1,156
- TALTZ (Drug) $835.44
- KRYSTEXXA (Biological) $741.81
- RINVOQ (Biological) $696.57
- COSENTYX (Biological) $693.20
- ACTHAR (Biological) $614.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Richmond
Dr. Karim Masri, M.d, M.D
Rheumatology — Payments: $220,639
Rheumatology $220,639
Tammy Spring, M.d, M.D
Rheumatology — Payments: $18,871
Rheumatology $18,871
Dr. Mihail Moroianu, M.d, M.D
Rheumatology — Payments: $16,532
Rheumatology $16,532
Dr. Peter Coutlakis, M.d, M.D
Rheumatology — Payments: $13,961
Rheumatology $13,961
Dr. Avnit Ahuja, Md, MD
Rheumatology — Payments: $9,294
Rheumatology $9,294
Bhakti Joshi, M.d, M.D
Rheumatology — Payments: $8,930
Rheumatology $8,930